Form 4 for DNTH Dianthus Therapeutics, Inc. /DE/
Accepted 2021-09-16 00:00:00 ET · period of report 2021-09-14 · accession 0000899243-21-036335 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-09-16 | 2021-09-14 | DNTH | GARDNER JASON | See Remarks, Dir | A - Grant | $0.00 | +50.0K | 301.2K | +20% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-14 | A | A | 50,000 | $0.00 | 301,212 | D | — | — |